Search research articles
Contact Us
Filters
Showing results (81-90 of 189) with videos related to
Page
of 19
Sort By:
Plos One
|
March 2, 2016
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
Gregory N Dietsch, Hailing Lu, Yi Yang, et al.
Cancer Research
|
January 21, 2006
Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain
James A Thompson, Samudra K Dissanayake, Bruce R Ksander, et al.
Journal of Clinical Immunology
|
September 15, 2005
Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells
Junbao Yang, Laurel Huston, Deanna Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 21, 2006
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice
Keith L Knutson, Yushe Dang, Hailing Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2012
Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells
Yushe Dang, Wolfgang M Wagner, Ekram Gad, et al.
Breast Cancer Research and Treatment
|
November 15, 2014
Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models
Ekram Gad, Lauren Rastetter, Meredith Slota, et al.
Biomaterials
|
April 27, 2010
Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment
Forrest M Kievit, Stephen J Florczyk, Matthew C Leung, et al.
Breast Cancer Research and Treatment
|
October 8, 2005
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals"
Masoud H Manjili, Hilal Arnouk, Keith L Knutson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 18, 2013
Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions
Elizabeth K Broussard, Rachel Kim, Jesse C Wiley, et al.
Innate Immunity
|
December 11, 2013
Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation
Yi Yang, Carol Inatsuka, Ekram Gad, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 189) with videos related to
Sort By:
Page
of 19
Plos One
|
March 2, 2016
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
Gregory N Dietsch, Hailing Lu, Yi Yang, et al.
Cancer Research
|
January 21, 2006
Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain
James A Thompson, Samudra K Dissanayake, Bruce R Ksander, et al.
Journal of Clinical Immunology
|
September 15, 2005
Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells
Junbao Yang, Laurel Huston, Deanna Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 21, 2006
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice
Keith L Knutson, Yushe Dang, Hailing Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2012
Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells
Yushe Dang, Wolfgang M Wagner, Ekram Gad, et al.
Breast Cancer Research and Treatment
|
November 15, 2014
Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models
Ekram Gad, Lauren Rastetter, Meredith Slota, et al.
Biomaterials
|
April 27, 2010
Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment
Forrest M Kievit, Stephen J Florczyk, Matthew C Leung, et al.
Breast Cancer Research and Treatment
|
October 8, 2005
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals"
Masoud H Manjili, Hilal Arnouk, Keith L Knutson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 18, 2013
Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions
Elizabeth K Broussard, Rachel Kim, Jesse C Wiley, et al.
Innate Immunity
|
December 11, 2013
Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation
Yi Yang, Carol Inatsuka, Ekram Gad, et al.
Page
of 19